Zobrazeno 1 - 9
of 9
pro vyhledávání: '"521"'
Publikováno v:
Vaccines, Vol 12, Iss 5, p 521 (2024)
State-level COVID-19 vaccination rates among older adults have been uneven in the United States. Due to the immunocompromised nature of older adults, vaccine hesitancy increases the risk of morbidity and mortality. This study aims to determine the as
Externí odkaz:
https://doaj.org/article/fd115eab0aac4fac9c9952b11f0da4dc
Autor:
Karolina Hoffmann, Anna Paczkowska, Michał Michalak, Marzena Jarząb, Wiesław Bryl, Elżbieta Nowakowska, Krzysztof Kus, Piotr Ratajczak, Tomasz Zaprutko, Dorota Kopciuch
Publikováno v:
Vaccines, Vol 12, Iss 1, p 23 (2023)
Background. There is sufficient scientific literature on the effectiveness of registered vaccines in preventing SARS-CoV-2 infection, but research on the impact of the COVID-19 vaccination program on social and economic aspects is lacking. In connect
Externí odkaz:
https://doaj.org/article/1eb819b6e7754f74ba1f7a6832ce3e48
Autor:
Natacha Bordry, Anne-Claire Mamez, Chiara Fedeli, Chloé Cantero, Cyril Jaksic, Pilar Ustero Alonso, Caroline Rayroux, Gregory Berra, Vera Portillo, Maeva Puntel, Sabine Yerly, Sébastien Bugeia, Garance Gutknecht, Mariagrazia Di Marco, Nicolas Mach, Paola Marina Soccal, Yves Chalandon, Alexandra Calmy, Alfredo Addeo
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1284 (2023)
Immunocompromised patients (ICPs) have a higher risk of developing severe forms of COVID-19 and experience a higher burden of complications and mortality than the general population. However, recent studies have suggested that the antibody response t
Externí odkaz:
https://doaj.org/article/a3d0d4b3586044cab2c911fd560b6d23
Autor:
Maria I. Brumboiu, Edina Iuga, Andreea Ivanciuc, Sergiu Mutaffof, Alice S. Tudosa, Cristina Gherasimovici, Irina Iaru
Publikováno v:
Vaccines, Vol 11, Iss 3, p 521 (2023)
The anti-COVID-19 vaccines, developed for use during the pandemic period, must be evaluated for effectiveness in order to coordinate the vaccination program. Therefore, this study aimed to measure the anti-COVID-19 vaccine effectiveness (VE) and dura
Externí odkaz:
https://doaj.org/article/a2ba6c414a5249b397edfb2af01db695
Autor:
Laura Bonzano, Olivera Djuric, Pamela Mancuso, Lidia Fares, Raffaele Brancaccio, Marta Ottone, Eufemia Bisaccia, Massimo Vicentini, Alessia Cocconcelli, Alfonso Motolese, Rostyslav Boyko, Paolo Giorgi Rossi, Alberico Motolese
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1111 (2022)
Compliance with vaccination is linked to its safety. In Italy, a plan to identify people who could be at an increased risk of adverse events (AEs) was defined so they could be vaccinated in a protected setting. We conducted an audit to describe the p
Externí odkaz:
https://doaj.org/article/28caebf1943f4791a6f3e992adf10a86
Autor:
Ndack Ndiaye, Fatou Diène Thiaw, Amary Fall, Ousmane Kébé, Khadija Leila Diatta, Ndongo Dia, Malick Fall, Amadou Alpha Sall, Martin Faye, Ousmane Faye
Publikováno v:
Vaccines, Vol 10, Iss 6, p 843 (2022)
Enterovirus A71 (EV-A71) is a non-polio enterovirus that currently represents a major public health concern worldwide. In Africa, only sporadic cases have been reported. Acute flaccid paralysis and environmental surveillance programs have been widely
Externí odkaz:
https://doaj.org/article/211cf8f7b81e49e5ac15c8d13aacc662
Publikováno v:
Vaccines, Vol 10, Iss 4, p 521 (2022)
Media reports have caused a significant drop in confidence in the AstraZeneca ChAdOx1 nCoV-19 COVID-19 vector vaccine (Vaxzevria, AstraZeneca Södertälje, Sweden). This has caused many people, already vaccinated with the first dose of AstraZeneca, t
Externí odkaz:
https://doaj.org/article/aac1bc5b043c45e1830a24e140f836de
Autor:
Andréa Gosset, Marie Libérée Nishimwe, Mamadou Yaya Diallo, Lucas Deroo, Aldiouma Diallo, El Hadji Ba, Patrizia Maria Carrieri, Cheikh Sokhna, Muriel Vray, Yusuke Shimakawa, Sylvie Boyer
Publikováno v:
Vaccines, Vol 9, Iss 5, p 521 (2021)
Some African countries are still reluctant to introduce the hepatitis B vaccine birth dose (HepB-BD) into their expanded program of immunization (EPI), partly because of logistical, economic, and cost information constraints. To assist decision-maker
Externí odkaz:
https://doaj.org/article/d9ecf888762c41e78cf24bc6579f36dd
Autor:
Federica Loi, Stefano Cappai, Alberto Laddomada, Francesco Feliziani, Annalisa Oggiano, Giulia Franzoni, Sandro Rolesu, Vittorio Guberti
Publikováno v:
Vaccines, Vol 8, Iss 3, p 521 (2020)
African swine fever (ASF) severely threatens the swine industry worldwide, given its spread and the absence of an available licensed vaccine, and has caused severe economic losses. Its persistence in wild boar (WB), longer than in domestic pig farms,
Externí odkaz:
https://doaj.org/article/11e77bedad144a60aac732ae8ef55f4c